Published in Epilepsia on July 01, 2000
PET Imaging of GABA Receptors in Succinic Semialdehyde Dehydrogenase Deficiency | NCT00246870
Brain Excitability in Patients With Succinic Semialdehyde Dehydrogenase Deficiency | NCT00132366
Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): standardized protocol and reference values. Pain (2006) 5.55
Are epilepsy classifications based on epileptic syndromes and seizure types outdated? Epileptic Disord (2006) 3.36
Cerebrospinal fluid tau and beta-amyloid 42 proteins identify Alzheimer disease in subjects with mild cognitive impairment. Arch Neurol (2002) 3.17
Semiological seizure classification. Epilepsia (1998) 2.96
Frequency, severity and duration of immune reconstitution events in HIV-related tuberculosis. Int J Tuberc Lung Dis (2007) 2.68
Differential effects on motorcortical inhibition induced by blockade of GABA uptake in humans. J Physiol (1999) 2.52
Structural basis for guanine nucleotide exchange on Ran by the regulator of chromosome condensation (RCC1). Cell (2001) 2.28
Consensus recommendations for MS cortical lesion scoring using double inversion recovery MRI. Neurology (2011) 2.17
The Microbleed Anatomical Rating Scale (MARS): reliability of a tool to map brain microbleeds. Neurology (2009) 2.14
Tau and Abeta42 protein in CSF of patients with frontotemporal degeneration. Neurology (2002) 2.12
Dominance for vestibular cortical function in the non-dominant hemisphere. Cereb Cortex (2003) 1.98
Quantum-coherent coupling of a mechanical oscillator to an optical cavity mode. Nature (2012) 1.97
Relation between baseline and on-treatment lipid parameters and first acute major coronary events in the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS). Circulation (2000) 1.85
Presynaptic depression at a calyx synapse: the small contribution of metabotropic glutamate receptors. J Neurosci (1997) 1.84
Normal IPT and IBZM SPECT in drug-naive and levodopa-treated idiopathic restless legs syndrome. Neurology (2001) 1.83
Cerebroretinal vasculopathy mimicking a brain tumor: a case of a rare hereditary syndrome. Neurology (1999) 1.81
Sample sizes for brain atrophy outcomes in trials for secondary progressive multiple sclerosis. Neurology (2008) 1.80
EANM procedure guidelines for brain tumour imaging using labelled amino acid analogues. Eur J Nucl Med Mol Imaging (2006) 1.79
Acute severe spinal cord dysfunction in bacterial meningitis in adults: MRI findings suggest extensive myelitis. Arch Neurol (2001) 1.79
Multisensory cortical signal increases and decreases during vestibular galvanic stimulation (fMRI). J Neurophysiol (2001) 1.79
Long-term follow-up of patients with neuromyelitis optica after repeated therapy with rituximab. Neurology (2011) 1.75
Cervical MR imaging in postural headache: MR signs and pathophysiological implications. AJNR Am J Neuroradiol (2001) 1.73
Intraoperative, probe-guided curettage of osteoid osteoma. Eur J Nucl Med (1993) 1.70
Brain microbleeds as a potential risk factor for antiplatelet-related intracerebral haemorrhage: hospital-based, case-control study. J Neurol Neurosurg Psychiatry (2010) 1.65
Reciprocal inhibitory visual-vestibular interaction. Visual motion stimulation deactivates the parieto-insular vestibular cortex. Brain (1998) 1.58
MRI outcomes in a placebo-controlled trial of natalizumab in relapsing MS. Neurology (2007) 1.56
Automatisms with preserved responsiveness: a lateralizing sign in psychomotor seizures. Neurology (1995) 1.52
The Wada test in Austrian, Dutch, German, and Swiss epilepsy centers from 2000 to 2005: a review of 1421 procedures. Epilepsy Behav (2008) 1.50
Intrasubject reproducibility of presurgical language lateralization and mapping using fMRI. Neurology (2003) 1.50
Cerebral metabolic patterns at early stages of frontotemporal dementia and semantic dementia. A PET study. Neurobiol Aging (2004) 1.48
Lasting cortical activation after repetitive TMS of the motor cortex: a glucose metabolic study. Neurology (2000) 1.46
High frequency of mitochondrial DNA mutations in glioblastoma multiforme identified by direct sequence comparison to blood samples. Int J Cancer (2001) 1.46
Comparison of technetium 99m polyclonal human immunoglobulin and technetium 99m monoclonal antibodies for imaging chronic osteomyelitis. First clinical results. Eur J Nucl Med (1991) 1.46
The differential expression of 16 NMDA and non-NMDA receptor subunits in the rat spinal cord and in periaqueductal gray. J Neurosci (1993) 1.46
Loss of neurons in the frontal cortex in AIDS brains. Acta Neuropathol (1990) 1.45
Sleep in Lennox-Gastaut syndrome: the role of the cyclic alternating pattern (CAP) in the gate control of clinical seizures and generalized polyspikes. Epilepsy Res (2001) 1.45
Expanding the international classification of seizures to provide localization information. Neurology (1993) 1.44
Region-specific encoding of sensory and affective components of pain in the human brain: a positron emission tomography correlation analysis. Ann Neurol (1999) 1.43
[Positron emission tomography for preoperative lymph node diagnosis in esophageal carcinoma]. Chirurg (2003) 1.42
Focal metabolic activation in the predominant left auditory cortex in patients suffering from tinnitus: a PET study with [18F]deoxyglucose. ORL J Otorhinolaryngol Relat Spec (1997) 1.42
Comparing propofol versus sevoflurane anesthesia for epileptogenic focus detection during positron emission tomography in pediatric patients. Minerva Anestesiol (2013) 1.40
[Placebo responders in randomized controlled drug trials of fibromyalgia syndrome : Systematic review and meta-analysis]. Schmerz (2011) 1.40
[Tau protein. A potential biological indicator for early detection of Alzheimer disease]. Nervenarzt (1998) 1.40
Multiparameter MR imaging in the 6-OPRI variant of inherited prion disease. AJNR Am J Neuroradiol (2013) 1.39
Decline of cerebral glucose metabolism in frontotemporal dementia: a longitudinal 18F-FDG-PET-study. Neurobiol Aging (2006) 1.39
Application of the National Cholesterol Education Program and joint European treatment criteria and clinical benefit in the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS). Eur Heart J (2000) 1.38
Reduced striatal dopamine transporters in idiopathic rapid eye movement sleep behaviour disorder. Comparison with Parkinson's disease and controls. Brain (2000) 1.35
High resolution MRI of the brain at 4.7 Tesla using fast spin echo imaging. Br J Radiol (2003) 1.32
Prospective evaluation of neurological complications after allogeneic bone marrow transplantation. Neurology (2003) 1.32
Click-chemistry reactions in radiopharmaceutical chemistry: fast & easy introduction of radiolabels into biomolecules for in vivo imaging. Curr Med Chem (2010) 1.31
Differential effects of fingolimod (FTY720) on immune cells in the CSF and blood of patients with MS. Neurology (2011) 1.31
The motor syndrome associated with exaggerated inhibition within the primary motor cortex of patients with hemiparetic. Brain (1997) 1.29
Spinal epidural cavernous hemangiomas. Report of three cases and review of the literature. J Neurosurg (1998) 1.26
PET and SPECT in epilepsy: a critical review. Epilepsy Behav (2009) 1.25
A positron emission tomographic study of subthalamic nucleus stimulation in Parkinson disease: enhanced movement-related activity of motor-association cortex and decreased motor cortex resting activity. Arch Neurol (1999) 1.23
The unpleasantness of tonic pain is encoded by the insular cortex. Neurology (2005) 1.22
Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS): efficacy and tolerability of long-term treatment with lovastatin in women. J Womens Health Gend Based Med (2001) 1.22
Neuroimaging findings in human prion disease. J Neurol Neurosurg Psychiatry (2006) 1.21
The neuropathology of heroin abuse. Forensic Sci Int (2000) 1.19
Schooling mediates brain reserve in Alzheimer's disease: findings of fluoro-deoxy-glucose-positron emission tomography. J Neurol Neurosurg Psychiatry (2006) 1.19
Aggressive confusional state as a clinical manifestation of status epilepticus in MELAS. Neurology (2003) 1.18
Noninvasive assessment of Crohn's disease activity: a comparison of 18F-fluorodeoxyglucose positron emission tomography, hydromagnetic resonance imaging, and granulocyte scintigraphy with labeled antibodies. Am J Gastroenterol (2002) 1.17
Regional myocardial sympathetic dysinnervation in arrhythmogenic right ventricular cardiomyopathy. An analysis using 123I-meta-iodobenzylguanidine scintigraphy. Circulation (1994) 1.17
In-vivo confocal real-time mini-microscopy in animal models of human inflammatory and neoplastic diseases. Endoscopy (2007) 1.17
Normal plasma levels of orexin A (hypocretin-1) in narcoleptic patients. Neurology (2001) 1.16
Central activation by histamine-induced itch: analogies to pain processing: a correlational analysis of O-15 H2O positron emission tomography studies. Pain (2001) 1.16
Statistical brain mapping of 18F-FDG PET in Alzheimer's disease: validation of anatomic standardization for atrophied brains. J Nucl Med (2001) 1.16
Normative volumetric data of the developing hippocampus in children based on magnetic resonance imaging. Epilepsia (1999) 1.14
Expression and signaling of group I metabotropic glutamate receptors in astrocytes and microglia. J Neurochem (1999) 1.13
In vitro and in vivo evaluation of novel glibenclamide derivatives as imaging agents for the non-invasive assessment of the pancreatic islet cell mass in animals and humans. Exp Clin Endocrinol Diabetes (2005) 1.13
REM sleep behavior disorder in sleep-disordered patients with versus without Parkinson's disease: is there a need for polysomnography? J Neurol Sci (2001) 1.12
Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TEXCAPS): additional perspectives on tolerability of long-term treatment with lovastatin. Am J Cardiol (2001) 1.10
CSF total and phosphorylated tau protein, regional glucose metabolism and dementia severity in Alzheimer's disease. Eur J Neurol (2008) 1.10
Distribution and developmental changes in metabotropic glutamate receptor messenger RNA expression in the rat lumbar spinal cord. Brain Res Dev Brain Res (1999) 1.09
Abnormalities of the balance between inhibition and excitation in the motor cortex of patients with cortical myoclonus. Brain (1996) 1.08
Coupling of cholesterol and cone-shaped lipids in bilayers augments membrane permeabilization by the cholesterol-specific toxins streptolysin O and Vibrio cholerae cytolysin. J Biol Chem (2001) 1.07
Gender differences in brain reserve : an (18)F-FDG PET study in Alzheimer's disease. J Neurol (2007) 1.07
6-18F-fluoro-L-dihydroxyphenylalanine positron emission tomography is superior to 123I-metaiodobenzyl-guanidine scintigraphy in the detection of extraadrenal and hereditary pheochromocytomas and paragangliomas: correlation with vesicular monoamine transporter expression. J Clin Endocrinol Metab (2010) 1.07
A review of structural magnetic resonance neuroimaging. J Neurol Neurosurg Psychiatry (2004) 1.06
Opioid receptors in the human cerebellum: evidence from [11C]diprenorphine PET, mRNA expression and autoradiography. Neuroreport (1999) 1.06
Sensory processing in Parkinson's and Huntington's disease: investigations with 3D H(2)(15)O-PET. Brain (1999) 1.06
Detailed magnetic resonance imaging anatomy of the cisternal segment of the abducent nerve: Dorello's canal and neurovascular relationships and landmarks. J Neurosurg (1999) 1.06
Expression of CB1 cannabinoid receptor in the anterior cingulate cortex in schizophrenia, bipolar disorder, and major depression. J Neural Transm (Vienna) (2007) 1.05
Automated continuous positive airway pressure titration for obstructive sleep apnea syndrome. Am J Respir Crit Care Med (1996) 1.05
Antibody response against gastrointestinal antigens in demyelinating diseases of the central nervous system. Eur J Neurol (2013) 1.05
MRI features of benign multiple sclerosis: toward a new definition of this disease phenotype. Neurology (2009) 1.04
Organization of cortical activities related to movement in humans. J Neurosci (2000) 1.04
PET imaging with yttrium-86: comparison of phantom measurements acquired with different PET scanners before and after applying background subtraction. Eur J Nucl Med Mol Imaging (2003) 1.03
Continuous transcranial magnetic stimulation during positron emission tomography: a suitable tool for imaging regional excitability of the human cortex. Neuroimage (2001) 1.03
Expression of metabotropic glutamate receptor subtype mRNA (mGluR1-8) in human cerebellum. Neuroreport (1999) 1.02